A Novel Epigenetic Drug-Eluting Balloon Angioplasty Device: Evaluation in a Large Animal Model of Neointimal Hyperplasia.
HongBin LiuMelissa ByrnePatrick PerlmutterAshley WalkerGopal R SamaJegadesan SubbiahBerkay OzcelikRobert E WiddopTracey A GaspariKeith ByronYung-Chih ChenDavid M KayeAnthony E DearPublished in: Cardiovascular drugs and therapy (2020)
Epi-Solve is a novel HDACi-coated DEBc which demonstrates significant anti-proliferative and anti-inflammatory signatures and reduced vascular endothelial cell activation compared to PABA in an ovine model and may afford endothelial protection.